Shukun Technology

Shukun Technology is a Beijing-based AI medical-imaging company that built a "digital human" platform spanning cardiology, neurology, chest and abdominal imaging . Its flagship "Digital Heart" family was the first in China to win an NMPA Class-III certificate for cardiac stenosis AI, in November 2020, and by late 2020 its products were in routine use at more than 400 tertiary hospitals including Peking Union Medical College Hospital and Beijing Anzhen Hospital . The firm later added a CT-FFR product, which gained its own NMPA Class-III approval in February 2023 . 5Y Capital led Shukun's Series A in July 2018 and has continued to back it through multiple rounds, including a RMB 590 million financing led by Sequoia China in late 2020 and a RMB 700 million round in mid-2021 that brought in Goldman Sachs Asset Management,春华资本 and others . The company has also pursued commercial partnerships, notably with Philips for cardiac CT solutions and with Meinian Health for chronic-disease screening .